Aerobic exercise capacity improvement of patients with human immunodeficiency virus one year post-treatment initiation by integrase inhibitors

Back

ESC Premium Access

Aerobic exercise capacity improvement of patients with human immunodeficiency virus one year post-treatment initiation by integrase inhibitors

Session: HIV and cardiovascular disease (1)

Topic: HIV and Cardiovascular Disease

Speaker: Doctor H. Triantafyllidi (Athens, GR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Helen Triantafyllidi

Attikon University Hospital, Athens (Greece)

0 follower

8 more presentations in this session

Effect of interleukin 1b inhibition with canakinumab on inflammation and viral persistence in people with human immunodeficiency virus

Speaker: Assistant Professor M. Durstenfeld (San Francisco, US)

Large-scale proteomic profiling reveals characteristic HIV-specific druggable protein signatures associated with incident heart failure

Speaker: Doctor S. Shakil (Los Angeles, US)

Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis.

Speaker: Professor N. Vuilleumier (Geneva, CH)

Influence of disturbed blood flow on endothelial function in people living with HIV

Speaker: Doctor A. Preveden (Sremska Kamenica, RS)

Impaired retinal micro-vascular function in patients with a systemic sclerosis

Speaker: Ms N. Laptseva (Zurich, CH)

Access the full session

HIV and cardiovascular disease (1)

Speakers: Doctor H. Triantafyllidi, Assistant Professor M. Durstenfeld, Doctor S. Shakil, Professor N. Vuilleumier, Doctor A. Preveden...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources